United States · FDA National Drug Code directory
Deflazacort
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0832-0817_55f5c3bf-2aa0-bd05-e063-6394a90ad3e6
- Product NDC
- 0832-0817
- Form
- TABLET
- Composition / generic term
- Deflazacort
- Labeler
- Upsher-Smith Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241105
- Source listing expiry
- 20271231
Source-listed ingredients
- DEFLAZACORT — 36 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (0832-0817-30) / 30 TABLET in 1 BOTTLE · 0832-0817-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →